Key points are not available for this paper at this time.
我们比较了替尼佐茨和米托尼佐茨对临床上耐米托尼佐茨的阴道毛滴虫分离株的体外活性。替尼佐茨的最小致死浓度(MLCs)显著低于米托尼佐茨的MLCs。米托尼佐茨耐药性增加与替尼佐茨耐药性增加相关。这些数据支持替尼佐茨在治疗阴道毛滴虫病中的作用。
Crowell等(Mon,)研究了这个问题。
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: